MammaPrint Feasibility in a Large Tertiary Urban Medical Center: An Initial Experience

Background. The MammaPrint (MP) diagnostic assay stratifies breast cancer patients into high- and low-risk groups using mRNA analysis of a 70-gene profile. The assay is validated for assessment of patients with estrogen receptor positive or negative tumors less than 5 cm with 3 or fewer malignant ly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Espinel, C. Francisco, Keating, Shaughn, Hibshoosh, Hanina, Taback, Bret, Joseph, Kathie-Ann, El-Tamer, Mahmoud, Feldman, Sheldon
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3820467/
https://ncbi.nlm.nih.gov/pubmed/24278759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6064/2012/942507
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars